Status:
COMPLETED
Impact of Weight Loss Interventions for Overweight Breast Cancer Survivors
Lead Sponsor:
University of Vermont
Collaborating Sponsors:
University of Vermont Medical Center
Conditions:
Overweight
Postmenopausal
Eligibility:
FEMALE
40-65 years
Phase:
NA
Brief Summary
Obesity is an epidemic and the majority of breast cancer survivors are overweight or obese. The American Cancer Society has called for weight loss treatment to be standard of care for overweight women...
Eligibility Criteria
Inclusion
- Post-menopausal (last period 12 mos prior to study enrollment or oophorectomy)
- Age 40-65
- DCIS, Stage I, II, III Breast Cancer
- BMI between 27-50
- Completed chemotherapy to treat early stage breast cancer (Stage I-III) no less then 6 months and no more than 48 months from start of study or for specific aim 3 Diagnosis of DCIS or Stage I breast cancer who did not receive chemotherapy.
Exclusion
- Participant can not have a psychotic or central nervous system impairment that would limit compliance with study requirements
- Evidence of metastatic disease
- Chemotherapy for cancer other than breast cancer
- Diabetes mellitus, uncontrolled hypo or hyper thyroidism, liver failure
- Celiac sprue, inflammatory bowel disease
- Inability to walk for exercise
- Lymphedema as indicated by a 2 cm circumference difference at the elbow
- weight loss in the previous 6 months of 10 lbs or greater
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT01482702
Start Date
October 1 2009
End Date
January 1 2012
Last Update
January 15 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vermont Cancer Center
Burlington, Vermont, United States, 05405